Scholarship INC.

ASSURANCE HALLMARK CONSOLIDÉE : TRIMESTRE 3 - ÉTATS FINANCIERS 2022 | MarketScreener

Houston Concierge Medicine Partners with Cardio Diagnostics to Offer the Epi+Gen CHD Test in its Executive Health Program | MarketScreener

Leave a Comment / Medicine / By

The leading concierge medicine practice in Houston will be the first concierge medicine practice to offer the Epi+Gen CHD precision test for cardiovascular disease to executives in Houston, TX. Cardio Diagnostics Holdings Inc (Nasdaq: CDIO), a leading precision cardiovascular diagnostics company, and Houston Concierge Medicine, a leading medical practice serving executives and health-conscious consumers in …

Houston Concierge Medicine Partners with Cardio Diagnostics to Offer the Epi+Gen CHD Test in its Executive Health Program | MarketScreener Read More »

ASSURANCE HALLMARK CONSOLIDÉE : TRIMESTRE 3 - ÉTATS FINANCIERS 2022 | MarketScreener

Alight Launches Targeted Behavioral Health and Cancer Offerings to Address Key Healthcare Challenges | MarketScreener

Leave a Comment / Mental health / By

Building on Alight’s existing deep clinical capabilities, robust analytics and consumer-centric content, two new comprehensive products enable employers to take a state-specific approach to providing personalized employee support. Alight, Inc. (NYSE: ALIT), a leading provider of cloud-based human capital technologies and services, is redefining the end-to-end healthcare experience and improving outcomes with two new products …

Alight Launches Targeted Behavioral Health and Cancer Offerings to Address Key Healthcare Challenges | MarketScreener Read More »

ASSURANCE HALLMARK CONSOLIDÉE : TRIMESTRE 3 - ÉTATS FINANCIERS 2022 | MarketScreener

Organicell Regenerative Medicine: Responds to Recent Promotional Activities as Demand from OTC Markets – Form 8-K | MarketScreener

Leave a Comment / Medicine / By

Organicell Regenerative Medicine, Inc. responds to recent promotional activities as requested by OTC markets Davie, Florida – November 21, 2022 – Organicell Regenerative Medicine, Inc. (OTCQB: OCEL) (“Organicell” or the “Company“) was requested by OTC Markets Group, Inc. (“OTC markets“) to release this statement on promotional activity regarding its common stock. On November 17, 2022, …

Organicell Regenerative Medicine: Responds to Recent Promotional Activities as Demand from OTC Markets – Form 8-K | MarketScreener Read More »

ASSURANCE HALLMARK CONSOLIDÉE : TRIMESTRE 3 - ÉTATS FINANCIERS 2022 | MarketScreener

MEDICINE MAN TECHNOLOGIES, INC. Management’s Discussion and Analysis of Financial Condition and Results of Operations (Form 10-Q) | MarketScreener

Leave a Comment / Medicine / By

The following discussion should be read in conjunction with our unaudited consolidated financial statements and notes thereto included herein and with our audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2021, as filed with the SEC. In addition to our historical unaudited condensed consolidated financial …

MEDICINE MAN TECHNOLOGIES, INC. Management’s Discussion and Analysis of Financial Condition and Results of Operations (Form 10-Q) | MarketScreener Read More »

Policymakers must change direction quickly in the post-pandemic era | MarketScreener

Policymakers must change direction quickly in the post-pandemic era | MarketScreener

Leave a Comment / Health care / By

This article originally appeared on The Conversation, an independent, nonprofit source of news, analysis and commentary from academic experts. Disclosure information is available on the original site. ___ Author: Sunil JohalTeacher, Public policy, University of Toronto Having faced the challenges of the COVID-19 pandemic, Canadians now find themselves facing even more challenges that impact their …

Policymakers must change direction quickly in the post-pandemic era | MarketScreener Read More »